Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Organic Letters|April 21, 2006
A retro-Claisen approach to dolabriferolTroy Lister, Michael V Perkins
Pharmaceutical Patent Analyst|December 21, 2013
New antibacterial agents: patent applications published in 2011Thomas A Keating, Troy Lister, Jeroen C Verheijen
Bioorganic & Medicinal Chemistry Letters|January 7, 2014
New natural products as new leads for antibacterial drug discoveryDean G Brown, Troy Lister, Tricia L May-Dracka
Current Opinion in Microbiology|May 28, 2016
Treatment of Gram-negative bacterial infections by potentiation of antibioticsThomas P Zabawa, Michael J Pucci, Thomas R Parr, et al.
Plos Neglected Tropical Diseases|July 26, 2021
In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaeraSacha J Pidot, Jessica L Porter, Troy Lister, et al.
Tetrahedron|May 23, 2009
Total synthesis of atrochamins F, H, I, and J through cascade reactionsK C Nicolaou, Troy Lister, Ross M Denton, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2018
Assessment of the In Vivo Activity of SPR741 in Combination with Azithromycin against Multidrug-Resistant Enterobacteriaceae Isolates in the Neutropenic Murine Thigh Infection ModelSean M Stainton, Kamilia Abdelraouf, Luke Utley, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 10, 2019
Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative PathogensRodrigo E Mendes, Paul R Rhomberg, Troy Lister, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae, Including Molecularly Characterized StrainsRodrigo E Mendes, Paul R Rhomberg, Troy Lister, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206Jon Bruss, Troy Lister, Vipul K Gupta, et al.
Pageof 3